Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Citrate-based materials fuel human stem cells by metabonegenic regulation.

Ma C, Tian X, Kim JP, Xie D, Ao X, Shan D, Lin Q, Hudock MR, Bai X, Yang J.

Proc Natl Acad Sci U S A. 2018 Nov 26. pii: 201813000. doi: 10.1073/pnas.1813000115. [Epub ahead of print]

PMID:
30478052
2.

Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism.

Selch S, Chafai A, Sticht H, Birkenfeld AL, Fromm MF, König J.

Sci Rep. 2018 Jul 27;8(1):11330. doi: 10.1038/s41598-018-29547-8.

3.

A fluorescent chemical probe CDy9 selectively stains and enables the isolation of live naïve mouse embryonic stem cells.

Cho SJ, Kim KT, Kim JS, Kwon OS, Go YH, Kang NY, Heo H, Kim MR, Han DW, Moon SH, Chang YT, Cha HJ.

Biomaterials. 2018 Oct;180:12-23. doi: 10.1016/j.biomaterials.2018.07.007. Epub 2018 Jul 5.

PMID:
30014963
4.

Extending the use of stiripentol to SLC13A5-related epileptic encephalopathy.

Alhakeem A, Alshibani F, Tabarki B.

Brain Dev. 2018 Oct;40(9):827-829. doi: 10.1016/j.braindev.2018.05.020. Epub 2018 Jun 9.

PMID:
29895383
5.

Common terms for rare epilepsies: Synonyms, associated terms, and links to structured vocabularies.

Grinspan ZM, Tian N, Yozawitz EG, McGoldrick PE, Wolf SM, McDonough TL, Nelson A, Hafeez B, Johnson SB, Hesdorffer DC.

Epilepsia Open. 2018 Jan 29;3(1):91-97. doi: 10.1002/epi4.12095. eCollection 2018 Mar.

6.

The longevity gene INDY (I'm Not Dead Yet) in metabolic control: Potential as pharmacological target.

Willmes DM, Kurzbach A, Henke C, Schumann T, Zahn G, Heifetz A, Jordan J, Helfand SL, Birkenfeld AL.

Pharmacol Ther. 2018 May;185:1-11. doi: 10.1016/j.pharmthera.2017.10.003. Epub 2017 Oct 5. Review.

7.

Flipping a citrate switch on liver cancer cells.

Peters JM.

J Biol Chem. 2017 Aug 18;292(33):13902-13903. doi: 10.1074/jbc.H117.783860. Review.

8.

Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle.

Bainbridge MN, Cooney E, Miller M, Kennedy AD, Wulff JE, Donti T, Jhangiani SN, Gibbs RA, Elsea SH, Porter BE, Graham BH.

Mol Genet Metab. 2017 Aug;121(4):314-319. doi: 10.1016/j.ymgme.2017.06.009. Epub 2017 Jun 24.

PMID:
28673551
9.

Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells.

Li Z, Li D, Choi EY, Lapidus R, Zhang L, Huang SM, Shapiro P, Wang H.

J Biol Chem. 2017 Aug 18;292(33):13890-13901. doi: 10.1074/jbc.M117.783860. Epub 2017 Jun 27.

10.

INDY-A New Link to Metabolic Regulation in Animals and Humans.

Rogina B.

Front Genet. 2017 May 24;8:66. doi: 10.3389/fgene.2017.00066. eCollection 2017. Review.

11.

Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice.

Irizarry AR, Yan G, Zeng Q, Lucchesi J, Hamang MJ, Ma YL, Rong JX.

PLoS One. 2017 Apr 13;12(4):e0175465. doi: 10.1371/journal.pone.0175465. eCollection 2017.

12.

Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.

Bhutia YD, Kopel JJ, Lawrence JJ, Neugebauer V, Ganapathy V.

Molecules. 2017 Feb 28;22(3). pii: E378. doi: 10.3390/molecules22030378. Review.

13.

The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism.

von Loeffelholz C, Lieske S, Neuschäfer-Rube F, Willmes DM, Raschzok N, Sauer IM, König J, Fromm MF, Horn P, Chatzigeorgiou A, Pathe-Neuschäfer-Rube A, Jordan J, Pfeiffer AFH, Mingrone G, Bornstein SR, Stroehle P, Harms C, Wunderlich FT, Helfand SL, Bernier M, de Cabo R, Shulman GI, Chavakis T, Püschel GP, Birkenfeld AL.

Hepatology. 2017 Aug;66(2):616-630. doi: 10.1002/hep.29089. Epub 2017 Jun 26.

14.

Placental and Cord Blood Methylation of Genes Involved in Energy Homeostasis: Association With Fetal Growth and Neonatal Body Composition.

Díaz M, García C, Sebastiani G, de Zegher F, López-Bermejo A, Ibáñez L.

Diabetes. 2017 Mar;66(3):779-784. doi: 10.2337/db16-0776. Epub 2016 Dec 16.

15.

Punctate white matter lesions in full-term infants with neonatal seizures associated with SLC13A5 mutations.

Weeke LC, Brilstra E, Braun KP, Zonneveld-Huijssoon E, Salomons GS, Koeleman BP, van Gassen KL, van Straaten HL, Craiu D, de Vries LS.

Eur J Paediatr Neurol. 2017 Mar;21(2):396-403. doi: 10.1016/j.ejpn.2016.11.002. Epub 2016 Nov 19.

PMID:
27913086
16.

Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.

Brachs S, Winkel AF, Tang H, Birkenfeld AL, Brunner B, Jahn-Hofmann K, Margerie D, Ruetten H, Schmoll D, Spranger J.

Mol Metab. 2016 Aug 13;5(11):1072-1082. doi: 10.1016/j.molmet.2016.08.004. eCollection 2016 Nov.

17.

State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281.

Rives ML, Shaw M, Zhu B, Hinke SA, Wickenden AD.

Mol Pharmacol. 2016 Dec;90(6):766-774. Epub 2016 Oct 17.

18.

Molecular Basis for Inhibition of the Na+/Citrate Transporter NaCT (SLC13A5) by Dicarboxylate Inhibitors.

Pajor AM, de Oliveira CA, Song K, Huard K, Shanmugasundaram V, Erion DM.

Mol Pharmacol. 2016 Dec;90(6):755-765. Epub 2016 Sep 28.

19.

SLC13A5 is the second gene associated with Kohlschütter-Tönz syndrome.

Schossig A, Bloch-Zupan A, Lussi A, Wolf NI, Raskin S, Cohen M, Giuliano F, Jurgens J, Krabichler B, Koolen DA, de Macena Sobreira NL, Maurer E, Muller-Bolla M, Penzien J, Zschocke J, Kapferer-Seebacher I.

J Med Genet. 2017 Jan;54(1):54-62. doi: 10.1136/jmedgenet-2016-103988. Epub 2016 Sep 6.

PMID:
27600704
20.

Determination of Unbound Partition Coefficient and in Vitro-in Vivo Extrapolation for SLC13A Transporter-Mediated Uptake.

Riccardi K, Li Z, Brown JA, Gorgoglione MF, Niosi M, Gosset J, Huard K, Erion DM, Di L.

Drug Metab Dispos. 2016 Oct;44(10):1633-42. doi: 10.1124/dmd.116.071837. Epub 2016 Jul 14.

Supplemental Content

Loading ...
Support Center